Overview

Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke

Status:
ENROLLING_BY_INVITATION

Trial end date:
2026-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety and feasibility of using intra-arterial Tenecteplase in patients undergoing blood clot extraction for treatment of acute ischemic (non-bleeding) stroke. Intravenous Tenecteplase is FDA-approved to treat patients with an ischemic stroke presenting within the 0-3-hour time window.

Phase:

PHASE2

Details

Lead Sponsor:

Wake Forest University Health Sciences

Collaborator:

Genentech, Inc.